A Study to Evaluate MAR002 for Acromegaly

NCT07641179 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: MAR002
DRUG: Placebo

Sponsor

Marea Therapeutics